Managers Buy Out Qwest Online Pharmaceutical Marketing Practice

Share this article:
Senior managers have bought the online pharmaceutical marketing practice of Qwest Communications International Inc. in a buyout funded by Edison Venture Fund, Lawrenceville, NJ.


The practice will run under the name Cadient, operating from its current offices in Philadelphia and Malvern, PA. A staff of 40 managers and executives will retain their jobs. Terms of the buyout were not disclosed.


Cadient will continue to create online pharmaceutical programs for clients like Procter & Gamble Co., Johnson & Johnson, GlaxoSmithKline and AstraZeneca. Cadient programs focus on the behavior of consumers and doctors to persuade them to sample, buy, prescribe and stay loyal to prescription and over-the-counter pharmaceutical brands.


Cadient clients will continue to receive network services from Qwest. The online pharmaceutical practice divestiture is part of a Qwest initiative to exit areas not in its core communications services.


Established in 1986 and run by 15 investment professionals, Edison has 115 investments in expansion-stage, $5 million to $15 million, companies in the Mid-Atlantic region. Edison typically invests $3 million to $5 million, serving as the sole or lead investor.


Share this article:

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in News

NBA Names Insurance Exec as its CMO

NBA Names Insurance Exec as its CMO

Nationwide and State Farm veteran Pamela El takes the league's marketing helm next month.

Bloomberg Names Bigley CMO

Bloomberg Names Bigley CMO

Communications chief Deirdre Bigley is appointed head of global marketing for the business and financial news company.

2014 Essential Guide to Omnichannel Marketing

2014 Essential Guide to Omnichannel Marketing

The 2014 Essential Guide to Omnichannel Marketing‚ÄĒeverything you need to know about Omnichannel, all in one spot. Read on for insight.